Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

APOE-Derived Peptides Attenuated Diabetes-Induced Oxidative Stress and Inflammation.

Nankar SA, Bulani Y, Sharma SS, Pande AH.

Protein Pept Lett. 2019 Oct 2. doi: 10.2174/0929866526666191002112655. [Epub ahead of print]

PMID:
31577194
2.

Protein Chimerization: A New Frontier for Engineering Protein Therapeutics with Improved Pharmacokinetics.

Iyengar ARS, Gupta S, Jawalekar S, Pande AH.

J Pharmacol Exp Ther. 2019 Sep;370(3):703-714. doi: 10.1124/jpet.119.257063. Epub 2019 Apr 22. Review.

PMID:
31010843
3.

Is Human Paraoxonase 1 the Saviour Against the Persistent Threat of Organophosphorus Nerve Agents?

Iyengar ARS, Pande AH.

Protein Pept Lett. 2019;26(7):471-478. doi: 10.2174/0929866526666190403120259. Review.

PMID:
30942142
4.

Antibiotic-free expression system for the production of human interferon-beta protein.

Pal D, Tripathy RK, Teja MS, Kumar M, Banerjee UC, Pande AH.

3 Biotech. 2018 Jan;8(1):36. doi: 10.1007/s13205-017-1056-3. Epub 2017 Dec 28.

5.

Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies.

Tripathy RK, Aggarwal G, Bajaj P, Kathuria D, Bharatam PV, Pande AH.

Appl Biochem Biotechnol. 2017 Aug;182(4):1642-1662. doi: 10.1007/s12010-017-2424-5. Epub 2017 Feb 4.

PMID:
28161867
6.
7.

Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.

Bajaj P, Tripathy RK, Aggarwal G, Datusalia AK, Sharma SS, Pande AH.

Appl Biochem Biotechnol. 2016 Sep;180(1):165-76. doi: 10.1007/s12010-016-2091-y. Epub 2016 Apr 30.

PMID:
27131877
8.

Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.

Aggarwal G, Prajapati R, Tripathy RK, Bajaj P, Iyengar AR, Sangamwar AT, Pande AH.

PLoS One. 2016 Feb 1;11(2):e0147999. doi: 10.1371/journal.pone.0147999. eCollection 2016.

9.

Improving Properties of Recombinant SsoPox by Site-Specific Pegylation.

Parikh H, Bajaj P, Tripathy RK, Pande AH.

Protein Pept Lett. 2015;22(12):1098-103.

PMID:
26428299
10.

Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.

Bajaj P, Tripathy RK, Aggarwal G, Pande AH.

Protein Expr Purif. 2015 Nov;115:95-101. doi: 10.1016/j.pep.2015.05.011. Epub 2015 May 21.

PMID:
26003526
11.

Expression, purification and immobilization of recombinant AiiA enzyme onto magnetic nanoparticles.

Beladiya C, Tripathy RK, Bajaj P, Aggarwal G, Pande AH.

Protein Expr Purif. 2015 Sep;113:56-62. doi: 10.1016/j.pep.2015.04.014. Epub 2015 May 14.

PMID:
25982248
12.

Improving storage stability of recombinant organophosphorus hydrolase.

Satvik Iyengar AR, Tripathy RK, Bajaj P, Pande AH.

Protein Expr Purif. 2015 Jul;111:28-35. doi: 10.1016/j.pep.2015.01.012. Epub 2015 Mar 14.

PMID:
25782740
13.

Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.

Bajaj P, Tripathy RK, Aggarwal G, Pande AH.

ScientificWorldJournal. 2014;2014:854391. doi: 10.1155/2014/854391. Epub 2014 Oct 20. Review.

14.

Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1.

Bajaj P, Aggarwal G, Tripathy RK, Pande AH.

Biochimie. 2014 Oct;105:202-10. doi: 10.1016/j.biochi.2014.07.024. Epub 2014 Aug 5.

PMID:
25107406
15.

Stabilization studies on bacterially produced human paraoxonase 1 for improving its shelf life.

Bajaj P, Pande AH.

Appl Biochem Biotechnol. 2014 Apr;172(8):3798-809. doi: 10.1007/s12010-014-0806-5. Epub 2014 Feb 27.

PMID:
24574251
16.

Properties of apolipoprotein E derived peptide modulate their lipid-binding capacity and influence their anti-inflammatory function.

Nankar SA, Pande AH.

Biochim Biophys Acta. 2014 Apr 4;1841(4):620-9. doi: 10.1016/j.bbalip.2014.01.006. Epub 2014 Jan 31.

PMID:
24486429
17.

Apolipoprotein E derived peptides inhibit the pro-inflammatory effect of lysophosphatidylcholine.

Nankar SA, Prajapati JS, Pande AH.

Protein Pept Lett. 2014;21(2):101-7.

PMID:
24151883
18.
19.

Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.

Kar S, Patel MA, Tripathy RK, Bajaj P, Pande AH.

Biochim Biophys Acta. 2013 Dec;1831(12):1714-20. doi: 10.1016/j.bbalip.2013.08.008. Epub 2013 Aug 23.

PMID:
23973798
20.

The chemical nature of the polar functional group of oxidized acyl chain uniquely modifies the physicochemical properties of oxidized phospholipid-containing lipid particles.

Kar S, Bajaj P, Tripathy RK, Pande AH.

J Membr Biol. 2013 Jun;246(6):443-52. doi: 10.1007/s00232-013-9556-5. Epub 2013 May 15.

PMID:
23673722
21.

Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs.

Nankar SA, Bajaj P, Sravanthi R, Pande AH.

Biochimie. 2013 Jun;95(6):1196-207. doi: 10.1016/j.biochi.2013.01.011. Epub 2013 Jan 30.

PMID:
23376877
22.

Physicochemical properties of bacterial pro-inflammatory lipids influence their interaction with apolipoprotein-derived peptides.

Nankar SA, Pande AH.

Biochim Biophys Acta. 2013 Apr;1831(4):853-62. doi: 10.1016/j.bbalip.2013.01.006. Epub 2013 Jan 16.

PMID:
23333883
23.

Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico.

Pérez-Cuevas R, Doubova SV, Suarez-Ortega M, Law M, Pande AH, Escobedo J, Espinosa-Larrañaga F, Ross-Degnan D, Wagner AK.

BMC Med Inform Decis Mak. 2012 Jun 6;12:50. doi: 10.1186/1472-6947-12-50.

24.

Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function.

Kar S, Patel MA, Tripathy RK, Bajaj P, Suvarnakar UV, Pande AH.

Biochim Biophys Acta. 2012 Sep;1821(9):1200-10. doi: 10.1016/j.bbalip.2012.05.002. Epub 2012 May 24.

PMID:
22634518
25.

Serious methodological flaws compromise study findings.

Pande AH, Soumerai SB.

BMJ. 2011 Sep 13;343:d5797; author reply 5800. doi: 10.1136/bmj.d5797. No abstract available.

PMID:
21914749
26.

Effects of healthcare reforms on coverage, access, and disparities: quasi-experimental analysis of evidence from Massachusetts.

Pande AH, Ross-Degnan D, Zaslavsky AM, Salomon JA.

Am J Prev Med. 2011 Jul;41(1):1-8. doi: 10.1016/j.amepre.2011.03.010.

PMID:
21665057
27.

A therapeutic chemical chaperone inhibits cholera intoxication and unfolding/translocation of the cholera toxin A1 subunit.

Taylor M, Banerjee T, Navarro-Garcia F, Huerta J, Massey S, Burlingame M, Pande AH, Tatulian SA, Teter K.

PLoS One. 2011 Apr 19;6(4):e18825. doi: 10.1371/journal.pone.0018825.

28.

Closely related oxidized phospholipids differentially modulate the physicochemical properties of lipid particles.

Kar S, Tillu VA, Meena SC, Pande AH.

Chem Phys Lipids. 2011 Jan;164(1):54-61. doi: 10.1016/j.chemphyslip.2010.10.006. Epub 2010 Nov 11.

PMID:
21074521
29.

Membrane lipid composition differentially modulates the function of human plasma platelet activating factor-acetylhydrolase.

Pande AH, Tillu VA.

Biochim Biophys Acta. 2011 Jan;1811(1):46-56. doi: 10.1016/j.bbalip.2010.09.002. Epub 2010 Sep 30.

PMID:
20869463
30.

Oxidatively modified fatty acyl chain determines physicochemical properties of aggregates of oxidized phospholipids.

Pande AH, Kar S, Tripathy RK.

Biochim Biophys Acta. 2010 Mar;1798(3):442-52. doi: 10.1016/j.bbamem.2009.12.028. Epub 2010 Jan 7.

31.

Stabilization of the tertiary structure of the cholera toxin A1 subunit inhibits toxin dislocation and cellular intoxication.

Massey S, Banerjee T, Pande AH, Taylor M, Tatulian SA, Teter K.

J Mol Biol. 2009 Nov 13;393(5):1083-96. doi: 10.1016/j.jmb.2009.09.013. Epub 2009 Sep 11.

32.

Peptide derived from the lipid binding domain of Group IB human pancreatic phospholipase A(2) possesses antibacterial activity.

Limbachiya MS, Pande AH.

Biochimie. 2009 Nov-Dec;91(11-12):1387-93. doi: 10.1016/j.biochi.2009.07.007. Epub 2009 Jul 18.

PMID:
19619604
33.

Membrane surface charge modulates lipoprotein complex forming capability of peptides derived from the C-terminal domain of apolipoprotein E.

Pande AH, Tripathy RK, Nankar SA.

Biochim Biophys Acta. 2009 Jun;1788(6):1366-76. doi: 10.1016/j.bbamem.2009.03.020. Epub 2009 Apr 8.

34.

Preferential binding of apolipoprotein E derived peptides with oxidized phospholipid.

Pande AH, Tripathy RK.

Biochem Biophys Res Commun. 2009 Feb 27;380(1):71-5. doi: 10.1016/j.bbrc.2009.01.029. Epub 2009 Jan 19.

PMID:
19159618
35.

Conformational instability of the cholera toxin A1 polypeptide.

Pande AH, Scaglione P, Taylor M, Nemec KN, Tuthill S, Moe D, Holmes RK, Tatulian SA, Teter K.

J Mol Biol. 2007 Dec 7;374(4):1114-28. Epub 2007 Oct 16.

36.

The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome.

Pande AH, Moe D, Jamnadas M, Tatulian SA, Teter K.

Biochemistry. 2006 Nov 21;45(46):13734-40.

37.

Structural and functional effects of tryptophans inserted into the membrane-binding and substrate-binding sites of human group IIA phospholipase A2.

Nemec KN, Pande AH, Qin S, Bieber Urbauer RJ, Tan S, Moe D, Tatulian SA.

Biochemistry. 2006 Oct 17;45(41):12448-60.

PMID:
17029400
38.

Isoform-specific membrane insertion of secretory phospholipase A2 and functional implications.

Pande AH, Qin S, Nemec KN, He X, Tatulian SA.

Biochemistry. 2006 Oct 17;45(41):12436-47.

PMID:
17029399
39.
40.

Evidence for the regulatory role of the N-terminal helix of secretory phospholipase A(2) from studies on native and chimeric proteins.

Qin S, Pande AH, Nemec KN, He X, Tatulian SA.

J Biol Chem. 2005 Nov 4;280(44):36773-83. Epub 2005 Aug 15.

41.

Positioning membrane proteins by novel protein engineering and biophysical approaches.

Tatulian SA, Qin S, Pande AH, He X.

J Mol Biol. 2005 Sep 2;351(5):939-47.

PMID:
16055150
42.

Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenase.

Pande AH, Qin S, Tatulian SA.

Biophys J. 2005 Jun;88(6):4084-94. Epub 2005 Mar 18.

43.

Modulation of human 5-lipoxygenase activity by membrane lipids.

Pande AH, Moe D, Nemec KN, Qin S, Tan S, Tatulian SA.

Biochemistry. 2004 Nov 23;43(46):14653-66. Erratum in: Biochemistry. 2005 Jan 11;44(1):440.

PMID:
15544336
44.
45.

Oxidation of goat hepatic galectin-1 induces change in secondary structure.

Pande AH, Gupta RK, Sumati, Hajela K.

Protein Pept Lett. 2003 Jun;10(3):265-75.

PMID:
12871146
46.

EPR studies on Fcgamma receptor-mediated changes in lymphocyte membrane.

Gupta RK, Pande AH, Sumati, Hajela K.

Indian J Biochem Biophys. 2003 Feb;40(1):59-61.

PMID:
22900293
47.
48.
50.

Prediction of peak expiratory flow rate from height and weight.

Pande AH.

Indian J Pediatr. 1986 Jul-Aug;53(4):521-3. No abstract available.

PMID:
3804393

Supplemental Content

Loading ...
Support Center